These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2737232)

  • 21. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of meropenem in subjects with renal insufficiency.
    Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G
    Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.
    Flouvat BL; Imbert C; Dubois DM; Temperville BP; Roux AF; Chevalier GC; Humbert G
    Br J Clin Pharmacol; 1983 Jun; 15(6):735-41. PubMed ID: 6871072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study.
    Bergner R; Dill K; Boerner D; Uppenkamp M
    Nephrol Dial Transplant; 2002 Jul; 17(7):1281-5. PubMed ID: 12105253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS
    Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoselective pharmacokinetics of ornidazole after intravenous administration of individual enantiomers and the racemate.
    Chen Y; Liu XQ; Zhong J; Zhao X; Wang Y; Wang G
    Chirality; 2006 Nov; 18(10):799-802. PubMed ID: 16906493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
    Drusano GL; Weir M; Forrest A; Plaisance K; Emm T; Standiford HC
    Antimicrob Agents Chemother; 1987 Jun; 31(6):860-4. PubMed ID: 3619418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiency.
    Kampf D; Schurig R; Korsukewitz I; Brückner O
    Antimicrob Agents Chemother; 1981 Dec; 20(6):741-6. PubMed ID: 7325641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of amine-vaginitis by a single dose of ornidazole (Tiberal); serum and tissue (vagina) concentrations of ornidazole after vaginal or rectal application.
    Petersen E; Sanabria de Isele T; Pelz K
    Chemioterapia; 1987 Jun; 6(2 Suppl):539-40. PubMed ID: 3509939
    [No Abstract]   [Full Text] [Related]  

  • 32. Single dose pharmacokinetics of lamivudine in subjects with impaired renal function and the effect of haemodialysis.
    Johnson MA; Verpooten GA; Daniel MJ; Plumb R; Moss J; Van Caesbroeck D; De Broe ME
    Br J Clin Pharmacol; 1998 Jul; 46(1):21-7. PubMed ID: 9690945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of oral and intravenous dolasetron mesylate in patients with renal impairment.
    Dimmitt DC; Shah AK; Arumugham T; Cramer MB; Halstenson C; Horton M; Weir SJ
    J Clin Pharmacol; 1998 Sep; 38(9):798-806. PubMed ID: 9753207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetic studies of ornidazole and metronidazole in man.
    Schwartz DE; Jeunet F
    Chemotherapy; 1976; 22(1):19-29. PubMed ID: 1253627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of impairment of renal function and dialysis on the serum and urine levels of clindamycin.
    Peddie BA; Dann E; Bailey RR
    Aust N Z J Med; 1975 Jun; 5(3):198-202. PubMed ID: 1057932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of renal function on risedronate pharmacokinetics after a single oral dose.
    Mitchell DY; St Peter JV; Eusebio RA; Pallone KA; Kelly SC; Russell DA; Nesbitt JD; Thompson GA; Powell JH
    Br J Clin Pharmacol; 2000 Mar; 49(3):215-22. PubMed ID: 10718776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tinidazole pharmacokinetics in severe renal failure.
    Robson RA; Bailey RR; Sharman JR
    Clin Pharmacokinet; 1984; 9(1):88-94. PubMed ID: 6692632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
    Lameire N; Malerczyk V; Drees B; Lehr K; Rosenkranz B
    Clin Pharmacol Ther; 1992 Jul; 52(1):24-30. PubMed ID: 1623690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M; Traina GL; Rosina R; Buniva G
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.